IP Library › Granted Patent US 8,859,506
Granted Patent B2
US 8,859,506 · App. 13/944,193 · Granted Oct 14, 2014

Glycopeptide phosphonate derivatives

Inventor: Michael R. Leadbetter (San Leandro, CA)
Assignee: Theravance Biopharma Antibiotics IP, LLC
C07K9/008A61K9/0019A61K9/2018A61K9/19A61K47/48969A61K47/06A61K9/0014A61K9/0095A61K9/4858A61K47/12A61K47/40A61K38/14A61K9/02A61K47/26B82Y5/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,859,506
App. No.
13/944,193
Granted
Oct 14, 2014
Kind
B2
Abstract

Disclosed are glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

Claims (4)

1. A compound of the formula:

or a pharmaceutically-acceptable salt thereof.

2. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of the formula:

or a pharmaceutically-acceptable salt thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033181/0646 →
Continuity (10)
Continuation 13328284 · Dec 16, 2011
Continuation 12715554 · Mar 2, 2010
Continuation 11977429 · Oct 24, 2007
Continuation 11584908 · Oct 23, 2006
Continuation 11265570 · Nov 2, 2005
Continuation 11037934 · Jan 18, 2005
Continuation 10669778 · Sep 24, 2003
Continuation 09847042 · May 1, 2001
Provisional Application 60213410 · Jun 22, 2000
Related Publication 20140024604A1 · Jan 23, 2014